MDA-MB-231 Cells [buňky MDA-MB-231]

topical
1
Terms

buněčná linie MDA-MB-231

 

MDA-MB-134 Breast Cancer Cells
MDA-MB-134 Breast Carcinoma Cells
MDA-MB-231 Cell Line

Persistent link   https://www.medvik.cz/link/D000092302
Definition

A human breast cancer cell line that was derived in 1973 from the MALIGNANT PLEURAL EFFUSION of a patient with stage III BREAST CARCINOMA and was characterized as being of breast cancer origin.

DUI
D000092302 MeSH Browser
CUI
M000751700
Previous indexing
Breast Neoplasms (1989-2022); Cell Line, Tumor (1989-2022)
History note
2023
Public note
2023

Allowable subheadings

CH
chemistry
CL
classification
CY
cytology
DE
drug effects
EN
enzymology
IM
immunology
ME
metabolism
MI
microbiology
PS
parasitology
PA
pathology
PH
physiology
RE
radiation effects
TR
transplantation
UL
ultrastructure
VI
virology

A Anatomy
A11 Cells 976
A11.251 Cells, Cultured 3 061
A11.251.210 Cell Line 1 920
A11.251.210.190 Cell Line, Tumor 2 044
A11.251.210.190.080 A549 Cells 60
A11.251.210.190.160 Caco-2 Cells 88
A11.251.210.190.380 HCT116 Cells 87
A11.251.210.190.400 HeLa Cells 639
A11.251.210.190.465 HL-60 Cells 168
A11.251.210.190.475 HT29 Cells 85
A11.251.210.190.495 Jurkat Cells 65
A11.251.210.190.510 K562 Cells 81
A11.251.210.190.630 MCF-7 Cells 152
A11.251.210.190.660 MDA-MB-231 Cells 1
A11.251.210.190.690 PC-3 Cells 20
A11.251.210.190.750 PC12 Cells 22
A11.251.210.190.815 THP-1 Cells 33
A11.251.210.190.880 U937 Cells 21
A11.251.860 Tumor Cells, Cultured 616
A11.251.860.180 Cell Line, Tumor 2 044
A11.251.860.180.080 A549 Cells 60
A11.251.860.180.160 Caco-2 Cells 88
A11.251.860.180.380 HCT116 Cells 87
A11.251.860.180.400 HeLa Cells 639
A11.251.860.180.432 Hep G2 Cells 197
A11.251.860.180.465 HL-60 Cells 168
A11.251.860.180.475 HT29 Cells 85
A11.251.860.180.495 Jurkat Cells 65
A11.251.860.180.510 K562 Cells 81
A11.251.860.180.630 MDA-MB-231 Cells 1
A11.251.860.180.750 PC12 Cells 22
A11.251.860.180.815 THP-1 Cells 33
A11.251.860.180.880 U937 Cells 21

Add